Is sarcopenic obesity superior to sarcopenia as a predicting indicator in patients with hepatocellular carcinoma following hepatic resection?
- PMID: 32355679
- PMCID: PMC7188538
- DOI: 10.21037/hbsn.2019.09.14
Is sarcopenic obesity superior to sarcopenia as a predicting indicator in patients with hepatocellular carcinoma following hepatic resection?
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/hbsn.2019.09.14). The authors have no conflicts of interest to declare.
Comment on
-
Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.Ann Surg. 2019 May;269(5):924-931. doi: 10.1097/SLA.0000000000002555. Ann Surg. 2019. PMID: 29064889
References
-
- Global Burden of Disease Liver Cancer Collaboration , Akinyemiju T, Abera S, et al. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol 2017;3:1683-91. 10.1001/jamaoncol.2017.3055 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources